Neurodegeneration in Multiple Sclerosis

Neurodegeneration in multiple sclerosis / , Neurodegeneration in multiple sclerosis / , کتابخانه دیجیتال جندی شاپور اهواز

[1]  J. Merrill,et al.  Stimulation of oligodendroglial proliferation and maturation by interleukin-2 , 1986, Nature.

[2]  Moses Rodriguez,et al.  Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis , 1996, Brain pathology.

[3]  G. Miller,et al.  Transgenic mice for interleukin 3 develop motor neuron degeneration associated with autoimmune reaction against spinal cord motor neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  P M Matthews,et al.  Imaging axonal damage of normal-appearing white matter in multiple sclerosis. , 1998, Brain : a journal of neurology.

[5]  E. Benveniste,et al.  Cytokine actions in the central nervous system. , 1998, Cytokine & growth factor reviews.

[6]  D. Arnold.  Magnetic resonance spectroscopy: imaging axonal damage in MS , 1999, Journal of Neuroimmunology.

[7]  M. Rovaris,et al.  Correlation between enhancing lesion number and volume on standard and triple dose gadolinium-enhanced brain MRI scans from patients with multiple sclerosis. , 1999, Magnetic resonance imaging.

[8]  R. Rudick,et al.  Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS , 1999, Neurology.

[9]  S. Hinderer,et al.  Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. , 2000, Brain : a journal of neurology.

[10]  S. Scherer,et al.  Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy. , 2000, Brain : a journal of neurology.

[11]  B. Trapp,et al.  NG2-Positive Oligodendrocyte Progenitor Cells in Adult Human Brain and Multiple Sclerosis Lesions , 2000, The Journal of Neuroscience.

[12]  David J. Anderson,et al.  The bHLH Transcription Factors OLIG2 and OLIG1 Couple Neuronal and Glial Subtype Specification , 2002, Cell.

[13]  S. Nelson,et al.  MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy , 2003, Journal of neurology, neurosurgery, and psychiatry.

[14]  E. Newman.  New roles for astrocytes: Regulation of synaptic transmission , 2003, Trends in Neurosciences.

[15]  R. Reynolds,et al.  Molecular Changes in Normal Appearing White Matter in Multiple Sclerosis are Characteristic of Neuroprotective Mechanisms Against Hypoxic Insult , 2003, Brain pathology.

[16]  A. Dale,et al.  Focal thinning of the cerebral cortex in multiple sclerosis. , 2003, Brain : a journal of neurology.

[17]  C. Lucchinetti,et al.  The pathology of primary progressive multiple sclerosis , 2004, Multiple sclerosis.

[18]  K. Nave,et al.  The myelin proteolipid protein gene modulates apoptosis in neural and non-neural tissues , 2004, Cell Death and Differentiation.

[19]  M Rovaris,et al.  Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis , 2004, Neurology.

[20]  B. Scheithauer,et al.  Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[21]  B. Stankoff,et al.  Promoting repair in multiple sclerosis: problems and prospects , 2005, Current opinion in neurology.

[22]  Hans Lassmann,et al.  Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.

[23]  S. Vukusic,et al.  Natural history of multiple sclerosis: a unifying concept. , 2006, Brain : a journal of neurology.

[24]  M. Esiri,et al.  The contribution of demyelination to axonal loss in multiple sclerosis. , 2006, Brain : a journal of neurology.

[25]  S. Vukusic,et al.  Accumulation of irreversible disability in multiple sclerosis: From epidemiology to treatment , 2006, Clinical Neurology and Neurosurgery.

[26]  Richard H. Price,et al.  Black Holes , 1997 .